Outcomes of NSCLC patients with positive EGFR mutation

被引:0
|
作者
Diver, Sarah
Haris, Mohammed
Khan, Shahul Leyakathali
Kerr, Jane
Edwards, Jane
Munavvar, Mohammed
机构
[1] Royal Preston Hosp, Med, Preston PR2 9HT, Lancs, England
[2] Royal Preston Hosp, Resp Med, Preston PR2 9HT, Lancs, England
[3] Royal Preston Hosp, Pathol, Preston PR2 9HT, Lancs, England
关键词
Lung cancer / Oncology;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
3269
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Comparison of Maintenance Therapy in EGFR Mutation Negative and EGFR Mutation Positive NSCLC Patients
    Joshi, Amit
    Noronha, Vanita
    Mahajan, Abhishek
    Janu, Amit
    Chougule, Anuradha
    Jambhekar, Nirmala
    Kumar, Rajeev
    Prabhash, Kumar
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S763 - S763
  • [2] Optimizing Patient Outcomes Through Sequential EGFR TKI Treatment in Asian Patients With EGFR Mutation-Positive NSCLC
    Liu, Rong
    Zhou, Jianying
    Ling, Xia
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [3] Optimizing Patient Outcomes Through Sequential EGFR TKI Treatment in Asian Patients With EGFR Mutation-Positive NSCLC
    Liu, Rong
    Zhou, Jianying
    Ling, Xia
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [4] Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs
    Liao, B-C.
    Bai, Y-Y.
    Lin, C-C.
    Lin, S-Y.
    Lee, Y-F.
    Ho, C-C.
    Shih, J-Y.
    Chang, Y-C.
    Yu, C-J.
    Yang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S123 - S124
  • [5] Management of CNS metastases in patients with EGFR mutation-positive NSCLC
    Shetty, Vijith
    Babu, Suresh
    INDIAN JOURNAL OF CANCER, 2019, 56 (05) : 31 - 37
  • [6] Effects of Ethnicity on Outcomes of Patients With EGFR Mutation-Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection
    Sung, Mike R.
    Tomasini, Pascale
    Le, Lisa W.
    Kamel-Reid, Suzanne
    Tsao, Ming-Sound
    Liu, Geoffrey
    Bradbury, Penelope A.
    Shepherd, Frances A.
    Li, Janice J. N.
    Feld, Ronald
    Leighl, Natasha B.
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (02):
  • [7] CLINICAL IMPACT OF EGFR MUTATION FRACTION AND TUMOUR CELLULARITY IN EGFR MUTATION POSITIVE NSCLC
    Martin, Petra
    Shiau, Carolyn
    Pasic, Maria D.
    Tsao, Ming-Sound
    Kamel-Reid, Suzanne
    Le, Lisa
    Higgins, Brian
    Cheng, Susanna
    Burkes, Ron
    Ng, Matilda
    Arif, Saroosh
    Tudor, Roxana
    Lin, Stephanie
    Ellis, Peter M.
    Hubay, Stacy
    Kuruvilla, Sara
    Laurie, Scott
    Li, Jing
    Shepherd, Frances A.
    Leighl, Natasha B.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1209 - S1210
  • [8] TREATMENT OF NSCLC PATIENTS WITH EGFR MUTATION
    Yang, J. C. -H.
    ANNALS OF ONCOLOGY, 2012, 23 : 29 - 29
  • [9] EGFR TKIS IN EGFR MUTATION-POSITIVE NSCLC WITH BRAIN METASTASIS
    Wu, Y. -L.
    ANNALS OF ONCOLOGY, 2012, 23 : 29 - 29
  • [10] BONE METASTASES ARE MORE FREQUENT AND MULTIPLE IN EGFR MUTATION POSITIVE NSCLC PATIENTS
    Ota, Keiichi
    Iwama, Eiji
    Takayama, Koichi
    Nakagaki, Noriaki
    Harada, Taishi
    Okamoto, Isamu
    Nakanishi, Yoichi
    RESPIROLOGY, 2013, 18 : 22 - 22